Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,002.11
+17.520.88%
Number of Gainers:724
Number of Losers:284
Number of Flat:13
PE:- -
High:2,007.66
Open:1,984.67
Low:1,984.67
Close:1,984.59
Volume:4.99B
Turnover:616.65B
Market Cap:95.80T
Float Cap:89.62T

Loading ...

Finn Partners Supports Textron Aviation as Agency of Record for 2026 Special Olympics Airlift

THOMSON REUTERS
·
Sep 05

AcroMeta Moves Into Cell Therapy Logistics With Southeast Asia ATCLS Deal

TIPRANKS
·
Sep 05

RES boosts treasury stock position amid ongoing share buyback

TIPRANKS
·
Sep 05

Iveco Board Backs €14.10-a-Share Tender Offer as Financially Fair

TIPRANKS
·
Sep 05

CONSOB Suspends Review of Rinova BidCo’s Tender Offer for Reway Group

TIPRANKS
·
Sep 05

Tandem Extends Tender Offer as It Nears Control of Compagnia dei Caraibi

TIPRANKS
·
Sep 05

Toscana Aeroporti’s Tuscan Hub Tops 7 Million Passengers by August in Record Year

TIPRANKS
·
Sep 05

Intesa Sanpaolo Reports Heavy Trading in HERA Shares on Italian Market

TIPRANKS
·
Sep 05

Neodecortech Lifts Treasury Share Holdings with New Buyback Tranche

TIPRANKS
·
Sep 05

Analysts Are Bullish on Top NA Stocks: VGP NV (VGPBF), Alphabet Class A (GOOGL)

TIPRANKS
·
Sep 05

Netflix Stock (NFLX) Falls 4% as Streamer Raises Price in the U.K.

TIPRANKS
·
Sep 05

UiPath's AI-Driven Deal Momentum, new Product Traction in Q2 are Encouraging, RBC Says

MT Newswires Live
·
Sep 05

UiPath Slips as Investors' Competition Concerns Persist

Dow Jones
·
Sep 05

Tesla Stock (NASDAQ:TSLA) Plunges, a Look at the Day After the Debut

TIPRANKS
·
Sep 05

Pfizer’s Next Move in Obesity Drugs: What the New VESPER-JM Trial Means for PFE Investors

TIPRANKS
·
Sep 05

Bristol-Myers Squibb Moves Into Depression Market With New Phase 2 Trial

TIPRANKS
·
Sep 05

Pfizer Steps Up in Obesity Race With New Phase 3 Berobenatide Trial in Japan

TIPRANKS
·
Sep 05

Novo Nordisk Advances New Obesity Drug NNC0721-8060 Into First Human Trial

TIPRANKS
·
Sep 05

Lilly Targets Type 1 Diabetes With New Tirzepatide Study: What Investors Should Watch

TIPRANKS
·
Sep 05

Pfizer’s Tilrekimig Eczema Trial: A Fresh Phase 3 Catalyst for PFE Investors

TIPRANKS
·
Sep 05